Jazz Pharmaceuticals plc (JAZZ) Profit Margins
Over the twelve months to 2026-06-30, Jazz Pharmaceuticals plc (JAZZ) had gross margin 56.0%, operating margin 19.5%, net margin 20.4%, free cash flow margin 31.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
JAZZJazz Pharmaceuticals plcFollow JAZZ — free
—
Price chart with a free account
- Market cap
- 13.9B
- P/E TTM
- 14.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | 72.6% | 52.1% | 52.4% | 36.9% | 50.1% | 51.7% | 32.3% | 56.0% | |
| Operating margin | 46.9% | 33.8% | 39.0% | 16.7% | 38.4% | 39.8% | 32.7% | 32.5% | 24.6% | 16.0% | 5.5% | -1.8% | 15.1% | 17.6% | -10.1% | 19.5% | |
| Net margin | 45.9% | 49.2% | 24.8% | 5.0% | 24.9% | 26.7% | 30.1% | 23.6% | 24.2% | 10.1% | -10.7% | -6.1% | 10.8% | 13.8% | -8.3% | 20.4% | |
| FCF margin | 55.2% | 41.6% | 31.9% | 31.7% | 37.4% | 39.2% | 41.0% | 41.2% | 34.1% | 37.4% | 24.3% | 34.0% | 27.9% | 33.4% | 30.4% | 31.2% |
USD billions · SEC XBRL
Jazz Pharmaceuticals plc — questions
- What is Jazz Pharmaceuticals plc's gross margin?
- 56.0% over the twelve months to 2026-06-30.
- What is Jazz Pharmaceuticals plc's operating margin?
- 19.5% over the twelve months to 2026-06-30.
- What is Jazz Pharmaceuticals plc's net profit margin?
- 20.4% over the twelve months to 2026-06-30.
Every figure on this page comes from Jazz Pharmaceuticals plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.